Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOBAPLATIN: 199 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
199
Total FAERS Reports
8 (4.0%)
Deaths Reported
88
Hospitalizations
199
As Primary/Secondary Suspect
19
Life-Threatening
7
Disabilities

First Report: 20160208 · Latest Report: 20250807

What Are the Most Common LOBAPLATIN Side Effects?

#1 Most Reported
Myelosuppression
84 reports (42.2%)
#2 Most Reported
White blood cell count decreased
21 reports (10.6%)
#3 Most Reported
Platelet count decreased
17 reports (8.5%)

All LOBAPLATIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Myelosuppression 84 42.2% 1 50
White blood cell count decreased 21 10.6% 0 12
Platelet count decreased 17 8.5% 1 11
Off label use 15 7.5% 1 8
Nausea 14 7.0% 1 5
Neutrophil count decreased 14 7.0% 0 7
Bone marrow failure 12 6.0% 0 5
Vomiting 11 5.5% 1 5
Hepatic function abnormal 10 5.0% 0 1
Rash 10 5.0% 0 3
Asthenia 9 4.5% 1 3
Diarrhoea 9 4.5% 2 3
Anaemia 8 4.0% 0 2
Gastrointestinal disorder 8 4.0% 0 0
Pyrexia 8 4.0% 0 6
Palmar-plantar erythrodysaesthesia syndrome 7 3.5% 0 0
Proteinuria 7 3.5% 0 0
Thrombocytopenia 7 3.5% 0 0
Decreased appetite 6 3.0% 0 3
Drug resistance 6 3.0% 0 0

Who Reports LOBAPLATIN Side Effects? Age & Gender Data

Gender: 65.5% female, 34.5% male. Average age: 57.6 years. Most reports from: CN. View detailed demographics →

Is LOBAPLATIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2016 2 0 1
2017 1 0 0
2018 5 0 4
2019 2 0 1
2020 14 2 9
2021 14 0 9
2022 16 0 8
2023 13 0 7
2024 38 0 26
2025 16 0 11

View full timeline →

What Is LOBAPLATIN Used For?

IndicationReports
Lung neoplasm malignant 19
Hepatocellular carcinoma 16
Breast cancer 12
Ovarian cancer 12
Lung adenocarcinoma 11
Oesophageal carcinoma 10
Adenocarcinoma 9
Chemotherapy 7
Oesophageal squamous cell carcinoma 5
Serous cystadenocarcinoma ovary 5

LOBAPLATIN vs Alternatives: Which Is Safer?

LOBAPLATIN vs LOFEXIDINE LOBAPLATIN vs LOMITAPIDE LOBAPLATIN vs LOMUSTINE LOBAPLATIN vs LONAPEGSOMATROPIN-TCGD LOBAPLATIN vs LONCASTUXIMAB TESIRINE-LPYL LOBAPLATIN vs LOPERAMIDE LOBAPLATIN vs LOPINAVIR LOBAPLATIN vs LOPINAVIR\RITONAVIR LOBAPLATIN vs LOPRAZOLAM LOBAPLATIN vs LORATADINE

Official FDA Label for LOBAPLATIN

Official prescribing information from the FDA-approved drug label.